9LUG
 
 | |
9B4X
 
 | |
9B8F
 
 | |
9B9U
 
 | |
9BBK
 
 | |
9BBP
 
 | |
9BBQ
 
 | SARS-CoV-2 Mpro in complex with compound 6c inhibitor | 分子名称: | 3C-like proteinase nsp5, N-[(2R)-1-({(2S)-1-amino-3-[(2S,3R)-2-hydroxypyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4'-ethoxy[1,1'-biphenyl]-4-carboxamide | 著者 | Afsar, M, Bury, P, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (1.78 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 6c inhibitor To Be Published
|
|
9BBR
 
 | SARS-CoV-2 Mpro in complex with compound 6b inhibitor | 分子名称: | 3C-like proteinase nsp5, 4'-fluoro-N-[(2S)-1-({(2R)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl][1,1'-biphenyl]-4-carboxamide | 著者 | Afsar, M, Bury, P, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2.15 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 6b inhibitor To Be Published
|
|
9BBS
 
 | |
9BBT
 
 | SARS-CoV-2 Mpro in complex with compound 6f inhibitor | 分子名称: | 3C-like proteinase nsp5, N-[(2S)-1-({(2R)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-3',4'-dimethoxy[1,1'-biphenyl]-4-carboxamide | 著者 | Afsar, M, Bury, P, Olsen, S.K, Nayak, A. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2.57 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 6f inhibitor To Be Published
|
|
9BBU
 
 | SARS-CoV-2 Mpro in complex with compound 6h inhibitor | 分子名称: | 1,2-ETHANEDIOL, 3C-like proteinase nsp5, N~2~-[4-(5-chloropyridin-3-yl)benzoyl]-N-{(1Z,2S)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | 著者 | Nayak, A, Afsar, M, Nayak, D, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 6h inhibitor To Be Published
|
|
9BBV
 
 | |
9BBW
 
 | |
9BBX
 
 | |
9BBY
 
 | SARS-CoV-2 Mpro in complex with compound 18b inhibitor | 分子名称: | 3-fluoro-N-[(2S)-1-({(2R)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4'-methoxy[1,1'-biphenyl]-4-carboxamide, 3C-like proteinase nsp5 | 著者 | Afsar, M, Bury, P, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 18b inhibitor To Be Published
|
|
9BBZ
 
 | SARS-CoV-2 Mpro in complex with compound 18d inhibitor | 分子名称: | 3C-like proteinase nsp5, N~2~-[(4M)-2-fluoro-4-(1-methyl-1H-indazol-5-yl)benzene-1-carbonyl]-N-{(1E,2S)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | 著者 | Afsar, M, Bury, P, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (1.62 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 18d inhibitor To Be Published
|
|
9BC0
 
 | SARS-CoV-2 Mpro in complex with compound 18r inhibitor | 分子名称: | 3-chloro-N-[(2R)-1-({(1Z,2S)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4'-methoxy[1,1'-biphenyl]-4-carboxamide, 3C-like proteinase nsp5 | 著者 | Afsar, M, Bury, P, Olsen, S.K. | 登録日 | 2024-04-07 | 公開日 | 2025-04-16 | 最終更新日 | 2025-05-14 | 実験手法 | X-RAY DIFFRACTION (2.08 Å) | 主引用文献 | SARS-CoV-2 Mpro in complex with compound 18r inhibitor To Be Published
|
|
9BD9
 
 | SARS CoV-2 full-length WT spike protein, 1RBD-up conformation (SPIKE-WT) | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Singh, S, Hasan, S.S. | 登録日 | 2024-04-11 | 公開日 | 2025-04-16 | 実験手法 | ELECTRON MICROSCOPY (2.95 Å) | 主引用文献 | Structure of SARS CoV-2 full-length spike protein, 1RBD-up conformation To Be Published
|
|
9BEA
 
 | |
9DHY
 
 | Structure of SARS-CoV-2 spike in complex with antibody Fab COVIC-154 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Antibody Fab COVIC-154 Heavy Chain, ... | 著者 | Yu, X, Saphire, E.O. | 登録日 | 2024-09-04 | 公開日 | 2025-04-16 | 実験手法 | ELECTRON MICROSCOPY (2.7 Å) | 主引用文献 | A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein. Cell Rep, 44, 2025
|
|
8WTS
 
 | SARS-CoV-2 3CLpro bound to covalent inhibitor | 分子名称: | (2~{R})-2-[[4-[chloranyl-bis(fluoranyl)methoxy]phenyl]-(2-chloranyl-2-fluoranyl-ethanoyl)amino]-~{N}-(oxan-4-yl)-2-pyrimidin-5-yl-propanamide, 1,2-ETHANEDIOL, 3C-like proteinase, ... | 著者 | Peng, J, Sun, D, Ding, X. | 登録日 | 2023-10-19 | 公開日 | 2025-04-23 | 最終更新日 | 2025-05-28 | 実験手法 | X-RAY DIFFRACTION (1.56 Å) | 主引用文献 | A novel, covalent broad-spectrum inhibitor targeting human coronavirus M pro. Nat Commun, 16, 2025
|
|
8Z2E
 
 | Crystal structure of nanobody Tnb04-1 with antibody 1F11 fab and SARS-CoV-2 RBD | 分子名称: | 1F11-H, 1F11-L, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Wang, X.Q, Zhang, L.Q, Chen, J, Dong, H.D. | 登録日 | 2024-04-12 | 公開日 | 2025-04-23 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Crystal structure of nanobody Tnb04-1 with antibody 1F11 fab and SARS-CoV-2 RBD To Be Published
|
|
9BC1
 
 | |
9GF7
 
 | SARS-CoV2 Main Protease (Mpro) in complex with the covalent inhibitor 28a | 分子名称: | 3C-like proteinase nsp5, ~{N}-[(2~{S})-4-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]quinoline-8-carboxamide | 著者 | Lolicato, M, Arrigoni, C. | 登録日 | 2024-08-08 | 公開日 | 2025-04-23 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P 3. Arch Pharm, 358, 2025
|
|
9KN1
 
 | |